Dace Rasina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Dace Rasina has a total of 102 co-authors. Here are the top co-authors by number of shared publications:
- Aigars Jirgensons
Latvian Institute of Organic Synthesis , Aizkraukles Street 21
9 shared publications Aigars Jirgensons
Organic Synthesis Methodology Group, Latvian Institute of Organic Synthesis, Riga, Latvia
4 shared publications- Kristaps Jaudzems
CNRS, ENS de Lyon, Lyon 1 Université Centre de RMN à Très Hauts Champs de Lyon (CRMN), UMR 5082 Villeurbanne France
4 shared publications Georgijs Stakanovs
Latvian Institute of Organic Synthesis, Aizkraukles str. 21, LV-1006, Riga, Latvia
3 shared publications- Luigi Vaccaro
Laboratory of Green S.O.C., Dipartimento di Chimica, Biologia e Biotecnologie, Università degli Studi di Perugia, Via Elce di Sotto 8, 06123, Perugia, Italy
3 shared publications - Raitis Bobrovs
Latvian Institute of Organic Synthesis Riga Latvia
3 shared publications
Latest Publications
- 16 September 2024
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 26 (38) , 8074-8078
Bioinspired Semisynthesis and Structure Revisions of Chlorinated Norsesquiterpenoids Rumphellatins A–C
The first synthesis of chlorine-containing hemiketals, rumphellatins A-C (1-3), previously inaccessible by means of total synthesis, was achieved starting from commercially available (-)-β-caryophyllene oxide (7). Structures of rumphellatins A (1) and C (3) were revised, while structures of rumphellatin B (2) and intermediate rumphellolide C (19) were confirmed. The study expands availability of exotic norsesquiterpenoids for profiling their biological activity as well as facilitates the elucidation of biosynthetic pathways of their formation.
- 16 September 2024
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 26 (38) , 8074-8078
Bioinspired Semisynthesis and Structure Revisions of Chlorinated Norsesquiterpenoids Rumphellatins A–C
The first synthesis of chlorine-containing hemiketals, rumphellatins A-C (1-3), previously inaccessible by means of total synthesis, was achieved starting from commercially available (-)-β-caryophyllene oxide (7). Structures of rumphellatins A (1) and C (3) were revised, while structures of rumphellatin B (2) and intermediate rumphellolide C (19) were confirmed. The study expands availability of exotic norsesquiterpenoids for profiling their biological activity as well as facilitates the elucidation of biosynthetic pathways of their formation.
- 2 October 2023
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 86 (10) , 2368-2378
Semisynthesis of Linariophyllenes A–C and Rumphellolide H, Structure Revisions and Proposed Biosynthesis Pathways
The first semisynthetic routes toward terrestrial anti-inflammatory natural products linariophyllene A-C and the refined route toward marine natural product rumphellolide H are presented. Among the synthesized target compounds, the correct structure of linariophyllene A was determined to be the diastereomer of the originally proposed structure with an inverted stereocenter at the secondary alcohol. The proposed structures of linariophyllene B and rumphellolide H were confirmed. However, the correct structure of linariophyllene C was found to be the diastereomer of the originally proposed structure with an inverted stereocenter at the tertiary carbon of the epoxide moiety. The structures of linariophyllenes A-C and rumphellolide H were unequivocally confirmed by single-crystal X-ray diffractometry. The obtained results enabled the proposal of the biosynthetic origins of the aforementioned natural products and bolstered the diversity of available sesquiterpenoids. Linariophyllenes A-C and rumphellolide H were obtained in sufficient amounts to further expand their bioactivity profile and utility as reference standards in future studies of chemical constituents of terrestrial and marine organisms.
- 2 October 2023
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 86 (10) , 2368-2378
Semisynthesis of Linariophyllenes A–C and Rumphellolide H, Structure Revisions and Proposed Biosynthesis Pathways
The first semisynthetic routes toward terrestrial anti-inflammatory natural products linariophyllene A-C and the refined route toward marine natural product rumphellolide H are presented. Among the synthesized target compounds, the correct structure of linariophyllene A was determined to be the diastereomer of the originally proposed structure with an inverted stereocenter at the secondary alcohol. The proposed structures of linariophyllene B and rumphellolide H were confirmed. However, the correct structure of linariophyllene C was found to be the diastereomer of the originally proposed structure with an inverted stereocenter at the tertiary carbon of the epoxide moiety. The structures of linariophyllenes A-C and rumphellolide H were unequivocally confirmed by single-crystal X-ray diffractometry. The obtained results enabled the proposal of the biosynthetic origins of the aforementioned natural products and bolstered the diversity of available sesquiterpenoids. Linariophyllenes A-C and rumphellolide H were obtained in sufficient amounts to further expand their bioactivity profile and utility as reference standards in future studies of chemical constituents of terrestrial and marine organisms.
- Open Access
- 28 July 2023
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 66 (15) , 10658-10680
Macrocyclic Peptidomimetic Plasmepsin X Inhibitors with Potent In Vitro and In Vivo Antimalarial Activity
The Plasmodium falciparum aspartic protease plasmepsin X (PMX) is essential for the egress of invasive merozoite forms of the parasite. PMX has therefore emerged as a new potential antimalarial target. Building on peptidic amino alcohols originating from a phenotypic screening hit, we have here developed a series of macrocyclic analogues as PMX inhibitors. Incorporation of an extended linker between the S1 phenyl group and S3 amide led to a lead compound that displayed a 10-fold improved PMX inhibitory potency and a 3-fold improved half-life in microsomal stability assays compared to the acyclic analogue. The lead compound was also the most potent of the new macrocyclic compounds in in vitro parasite growth inhibition. Inhibitor 7k cleared blood-stage P. falciparum in a dose-dependent manner when administered orally to infected humanized mice. Consequently, lead compound 7k represents a promising orally bioavailable molecule for further development as a PMX-targeting antimalarial drug.
- 28 July 2023
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 66 (15) , 10658-10680
Open AccessMacrocyclic Peptidomimetic Plasmepsin X Inhibitors with Potent In Vitro and In Vivo Antimalarial Activity
The Plasmodium falciparum aspartic protease plasmepsin X (PMX) is essential for the egress of invasive merozoite forms of the parasite. PMX has therefore emerged as a new potential antimalarial target. Building on peptidic amino alcohols originating from a phenotypic screening hit, we have here developed a series of macrocyclic analogues as PMX inhibitors. Incorporation of an extended linker between the S1 phenyl group and S3 amide led to a lead compound that displayed a 10-fold improved PMX inhibitory potency and a 3-fold improved half-life in microsomal stability assays compared to the acyclic analogue. The lead compound was also the most potent of the new macrocyclic compounds in in vitro parasite growth inhibition. Inhibitor 7k cleared blood-stage P. falciparum in a dose-dependent manner when administered orally to infected humanized mice. Consequently, lead compound 7k represents a promising orally bioavailable molecule for further development as a PMX-targeting antimalarial drug.
- 17 June 2022
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 62 (13) , 3263-3273
Exploring Aspartic Protease Inhibitor Binding to Design Selective Antimalarials
Selectivity is a major issue in the development of drugs targeting pathogen aspartic proteases. Here, we explore the selectivity-determining factors by studying specifically designed malaria aspartic protease (plasmepsin) open-flap inhibitors. Metadynamics simulations are used to uncover the complex binding/unbinding pathways of these inhibitors and describe the critical transition states in atomistic resolution. The simulation results are compared with experimentally determined enzymatic activities. Our findings demonstrate that plasmepsin inhibitor selectivity can be achieved by targeting the flap loop with hydrophobic substituents that enable ligand binding under the flap loop, as such a behavior is not observed for several other aspartic proteases. The ability to estimate the selectivity of compounds before they are synthesized is of considerable importance in drug design; therefore, we expect that our approach will be useful in selective inhibitor designs against not only aspartic proteases but also other enzyme classes.
- 17 June 2022
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 62 (13) , 3263-3273
Exploring Aspartic Protease Inhibitor Binding to Design Selective Antimalarials
Selectivity is a major issue in the development of drugs targeting pathogen aspartic proteases. Here, we explore the selectivity-determining factors by studying specifically designed malaria aspartic protease (plasmepsin) open-flap inhibitors. Metadynamics simulations are used to uncover the complex binding/unbinding pathways of these inhibitors and describe the critical transition states in atomistic resolution. The simulation results are compared with experimentally determined enzymatic activities. Our findings demonstrate that plasmepsin inhibitor selectivity can be achieved by targeting the flap loop with hydrophobic substituents that enable ligand binding under the flap loop, as such a behavior is not observed for several other aspartic proteases. The ability to estimate the selectivity of compounds before they are synthesized is of considerable importance in drug design; therefore, we expect that our approach will be useful in selective inhibitor designs against not only aspartic proteases but also other enzyme classes.
- 3 March 2022
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 20 (12) , 2455-2461
Convergent biomimetic semisynthesis of disesquiterpenoid rumphellolide J
The gram-scale synthesis of disesquiterpenoid ester rumphellolide J (5) from (−)-β-caryophyllene (1) and (−)-caryophyllene oxide (3) via natural products 4β,8β-epoxycaryophyllan-5-ol (2) and (+)-rumphellaoic acid A (4) is demonstrated.
- 3 March 2022
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 20 (12) , 2455-2461
Convergent biomimetic semisynthesis of disesquiterpenoid rumphellolide J
The gram-scale synthesis of disesquiterpenoid ester rumphellolide J (5) from (−)-β-caryophyllene (1) and (−)-caryophyllene oxide (3) via natural products 4β,8β-epoxycaryophyllan-5-ol (2) and (+)-rumphellaoic acid A (4) is demonstrated.
- 15 June 2020
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 83 (6) , 2004-2009
A Concise Bioinspired Semisynthesis of Rumphellaones A–C and Their C-8 Epimers from β-Caryophyllene
The first semisynthetic route toward rumphellaones B (2) and C (3) and their C-8 epimers as well as the shortest synthesis of rumphellaone A (1) and its C-8 epimer from the most accessible sesquiterpene, β-caryophyllene (4), is presented. Synthetic routes involved caryophyllonic acid as a key intermediate, which was converted to rumphellaone A (and epimer) via acid-catalyzed lactonization and rumphellaone C (and epimer) using one-pot epoxidation–lactonization. Rumphellaone B (2) and its epimer were obtained from rumphellaone A (1) and its epimer, respectively, using Saegusa–Ito oxidation. The absolute configuration at C-8 was confirmed by single-crystal X-ray analysis of rumphellaone B (2) and an acylated derivative of rumphellaone C.
- 15 June 2020
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 83 (6) , 2004-2009
A Concise Bioinspired Semisynthesis of Rumphellaones A–C and Their C-8 Epimers from β-Caryophyllene
The first semisynthetic route toward rumphellaones B (2) and C (3) and their C-8 epimers as well as the shortest synthesis of rumphellaone A (1) and its C-8 epimer from the most accessible sesquiterpene, β-caryophyllene (4), is presented. Synthetic routes involved caryophyllonic acid as a key intermediate, which was converted to rumphellaone A (and epimer) via acid-catalyzed lactonization and rumphellaone C (and epimer) using one-pot epoxidation–lactonization. Rumphellaone B (2) and its epimer were obtained from rumphellaone A (1) and its epimer, respectively, using Saegusa–Ito oxidation. The absolute configuration at C-8 was confirmed by single-crystal X-ray analysis of rumphellaone B (2) and an acylated derivative of rumphellaone C.
- Open Access
- 1 March 2019
- Published by Elsevier in SLAS Discovery
- Vol. 24 (3) , 398-413
EU-OPENSCREEN: A Novel Collaborative Approach to Facilitate Chemical Biology
- 1 March 2019
- Published by Elsevier in SLAS Discovery
- Vol. 24 (3) , 398-413
Open AccessEU-OPENSCREEN: A Novel Collaborative Approach to Facilitate Chemical Biology
- 1 May 2018
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 26 (9) , 2488-2500
2-Aminoquinazolin-4(3H)-one based plasmepsin inhibitors with improved hydrophilicity and selectivity
- 1 May 2018
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 26 (9) , 2488-2500
2-Aminoquinazolin-4(3H)-one based plasmepsin inhibitors with improved hydrophilicity and selectivity
- 3 April 2017
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 2017 (13) , 1773-1779
N‐Sulfonylcarboxamide as an Oxidizing Directing Group for Ruthenium‐Catalyzed C–H Activation/Annulation
N‐Sulfonylcarboxamides can act as both a directing group for C–H activation and an internal oxidant in the Ru‐catalyzed annulation reaction with alkynes to give isoquinolones. Of all of the N‐sulfonylcarboxamides that were studied, the N‐(2,6‐difluorophenyl)sulfonamide derivatives were found to be the most efficient and led to the formation of an unstable sulfinate byproduct that decomposed into 1,3‐difluorobenzene under the reaction conditions. The described isoquinolone synthesis provides an alternative to the currently known traceless annulations of hydroxamic acid and sulfoximine derivatives.
- 3 April 2017
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 2017 (13) , 1773-1779
N‐Sulfonylcarboxamide as an Oxidizing Directing Group for Ruthenium‐Catalyzed C–H Activation/Annulation
N‐Sulfonylcarboxamides can act as both a directing group for C–H activation and an internal oxidant in the Ru‐catalyzed annulation reaction with alkynes to give isoquinolones. Of all of the N‐sulfonylcarboxamides that were studied, the N‐(2,6‐difluorophenyl)sulfonamide derivatives were found to be the most efficient and led to the formation of an unstable sulfinate byproduct that decomposed into 1,3‐difluorobenzene under the reaction conditions. The described isoquinolone synthesis provides an alternative to the currently known traceless annulations of hydroxamic acid and sulfoximine derivatives.
- 1 October 2016
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 60 (10) , 6359-6361
Targeting Multiple Aminoacyl-tRNA Synthetases Overcomes the Resistance Liabilities Associated with Antibacterial Inhibitors Acting on a Single Such Enzyme
Bacterial aminoacyl-tRNA synthetases (aaRSs) represent promising antibacterial drug targets. Unfortunately, the aaRS inhibitors that have to date reached clinical trials are subject to rapid resistance development through mutation, a phenomenon that limits their potential clinical utility. Here, we confirm the intuitively correct idea that simultaneous targeting of two different aaRS enzymes prevents the emergence of spontaneous bacterial resistance at high frequency, a finding that supports the development of multitargeted anti-aaRS therapies.
- 1 October 2016
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 60 (10) , 6359-6361
Targeting Multiple Aminoacyl-tRNA Synthetases Overcomes the Resistance Liabilities Associated with Antibacterial Inhibitors Acting on a Single Such Enzyme
Bacterial aminoacyl-tRNA synthetases (aaRSs) represent promising antibacterial drug targets. Unfortunately, the aaRS inhibitors that have to date reached clinical trials are subject to rapid resistance development through mutation, a phenomenon that limits their potential clinical utility. Here, we confirm the intuitively correct idea that simultaneous targeting of two different aaRS enzymes prevents the emergence of spontaneous bacterial resistance at high frequency, a finding that supports the development of multitargeted anti-aaRS therapies.